119 related articles for article (PubMed ID: 2668802)
1. The effects of N-acetylated alpha-linked acidic dipeptidase (NAALADase) inhibitors on [3H]NAAG catabolism in vivo.
Stauch BL; Robinson MB; Forloni G; Tsai G; Coyle JT
Neurosci Lett; 1989 May; 100(1-3):295-300. PubMed ID: 2668802
[TBL] [Abstract][Full Text] [Related]
2. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate: subcellular and regional distribution, ontogeny, and the effect of lesions on N-acetylated-alpha-linked acidic dipeptidase activity.
Blakely RD; Robinson MB; Thompson RC; Coyle JT
J Neurochem; 1988 Apr; 50(4):1200-9. PubMed ID: 3346674
[TBL] [Abstract][Full Text] [Related]
3. Competitive inhibition of N-acetylated-alpha-linked acidic dipeptidase activity by N-acetyl-L-aspartyl-beta-linked L-glutamate.
Serval V; Barbeito L; Pittaluga A; Cheramy A; Lavielle S; Glowinski J
J Neurochem; 1990 Jul; 55(1):39-46. PubMed ID: 2355230
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase).
Slusher BS; Tsai G; Yoo G; Coyle JT
J Comp Neurol; 1992 Jan; 315(2):217-29. PubMed ID: 1545010
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated alpha-linked acidic dipeptidase.
Jackson PF; Cole DC; Slusher BS; Stetz SL; Ross LE; Donzanti BA; Trainor DA
J Med Chem; 1996 Jan; 39(2):619-22. PubMed ID: 8558536
[TBL] [Abstract][Full Text] [Related]
6. A re-examination of the interaction of N-acetyl-L-aspartyl-L-glutamate with a subpopulation of rat brain membrane L-[3H]glutamate binding sites.
Blakely RD; Robinson MB; Guarda AS; Coyle JT
Eur J Pharmacol; 1988 Jul; 151(3):419-26. PubMed ID: 2850921
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo inhibition of N-acetyl-L-aspartyl-L-glutamate catabolism by N-acylated L-glutamate analogs.
Serval V; Galli T; Cheramy A; Glowinski J; Lavielle S
J Pharmacol Exp Ther; 1992 Mar; 260(3):1093-100. PubMed ID: 1545381
[TBL] [Abstract][Full Text] [Related]
8. N-Acetylated alpha-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin.
Thomas AG; Vornov JJ; Olkowski JL; Merion AT; Slusher BS
J Pharmacol Exp Ther; 2000 Oct; 295(1):16-22. PubMed ID: 10991955
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.
Carter RE; Feldman AR; Coyle JT
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):749-53. PubMed ID: 8570628
[TBL] [Abstract][Full Text] [Related]
10. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains.
Tsai G; Passani LA; Slusher BS; Carter R; Baer L; Kleinman JE; Coyle JT
Arch Gen Psychiatry; 1995 Oct; 52(10):829-36. PubMed ID: 7575102
[TBL] [Abstract][Full Text] [Related]
11. Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetyl-aspartyl-glutamate.
Meyerhoff JL; Carter RE; Yourick DL; Slusher BS; Coyle JT
Brain Res; 1992 Oct; 593(1):140-3. PubMed ID: 1360862
[TBL] [Abstract][Full Text] [Related]
12. Synaptosomal transport of radiolabel from N-acetyl-aspartyl-[3H]glutamate suggests a mechanism of inactivation of an excitatory neuropeptide.
Blakely RD; Ory-Lavollée L; Thompson RC; Coyle JT
J Neurochem; 1986 Oct; 47(4):1013-9. PubMed ID: 2875126
[TBL] [Abstract][Full Text] [Related]
13. Seizures decrease regional enzymatic hydrolysis of N-acetyl-aspartylglutamate in rat brain.
Meyerhoff JL; Robinson MB; Bixler MA; Richards SS; Coyle JT
Brain Res; 1989 Dec; 505(1):130-4. PubMed ID: 2611666
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury.
Slusher BS; Vornov JJ; Thomas AG; Hurn PD; Harukuni I; Bhardwaj A; Traystman RJ; Robinson MB; Britton P; Lu XC; Tortella FC; Wozniak KM; Yudkoff M; Potter BM; Jackson PF
Nat Med; 1999 Dec; 5(12):1396-402. PubMed ID: 10581082
[TBL] [Abstract][Full Text] [Related]
15. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain.
Robinson MB; Blakely RD; Couto R; Coyle JT
J Biol Chem; 1987 Oct; 262(30):14498-506. PubMed ID: 3667587
[TBL] [Abstract][Full Text] [Related]
16. Blockade of NAALADase: a novel neuroprotective strategy based on limiting glutamate and elevating NAAG.
Vornov JJ; Wozniak K; Lu M; Jackson P; Tsukamoto T; Wang E; Slusher B
Ann N Y Acad Sci; 1999; 890():400-5. PubMed ID: 10668445
[TBL] [Abstract][Full Text] [Related]
17. N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases.
Passani LA; Vonsattel JP; Carter RE; Coyle JT
Mol Chem Neuropathol; 1997 Jun; 31(2):97-118. PubMed ID: 9376025
[TBL] [Abstract][Full Text] [Related]
18. Measurement of glutamate carboxypeptidase II (NAALADase) enzyme activity by the hydrolysis of [³H]-N-acetylaspartylglutamate (NAAG).
Tiffany CW; Slusher BS
Curr Protoc Pharmacol; 2002 Feb; Chapter 3():Unit3.10. PubMed ID: 21959764
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation.
Thomas AG; Olkowski JL; Slusher BS
Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768
[TBL] [Abstract][Full Text] [Related]
20. Design of NAALADase inhibitors: a novel neuroprotective strategy.
Jackson PF; Slusher BS
Curr Med Chem; 2001 Jul; 8(8):949-57. PubMed ID: 11375762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
